Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling
This is the first study to demonstrate the ability of plasma proteomics to predict new-onset AF in HCM and identify dysregulated signalling pathways.
Authors
- Nina Harano
- Muredach P. Reilly (ORCID: https://orcid.org/0000-0002-3035-9386)
- Kohei Hasegawa (ORCID: https://orcid.org/0000-0002-5739-7999)
- Albree Tower‐Rader
- Lusha W. Liang (ORCID: https://orcid.org/0000-0003-3931-4085)
- Mathew S. Maurer (ORCID: https://orcid.org/0000-0001-5400-5008)
- Yuichi J. Shimada (ORCID: https://orcid.org/0000-0002-3494-307X)
- Michael A. Fifer (ORCID: https://orcid.org/0000-0002-8363-445X)
- Heidi Hartman (ORCID: https://orcid.org/0000-0002-5154-0221)
Institutions
- Harvard University (US)
- Columbia University Irving Medical Center (US)
- Massachusetts General Hospital (US)
- Columbia University (US)
Publication Details
- Journal
- EP Europace
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1093/europace/euae267
- Citations
- 2
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- American Heart Association
- Feldstein Medical Foundation
- Korea Institute of Oriental Medicine
- National Institutes of Health
- Irving Medical Center, Columbia University